CDXS
- Codexis, Inc.
()
Overview
Company Summary
Codexis, Inc. is a biotechnology company that specializes in protein engineering. The company focuses on the development and application of custom enzymes to create improved biocatalysts for use in various industries.
Codexis utilizes its proprietary CodeEvolver platform, which combines computational protein modeling with high-throughput screening, to design enzymes with enhanced performance characteristics. These enzymes can be used in a variety of processes, such as pharmaceutical manufacturing, food production, and sustainable energy production.
The primary goal of Codexis is to provide its customers with sustainable and cost-effective solutions by developing enzymes that are more efficient, specific, and stable than traditional catalysts. This allows for improved process performance, reduced waste generation, and increased yields.
In the pharmaceutical industry, Codexis works with global partners to develop and manufacture biocatalysts for the production of active pharmaceutical ingredients (APIs), enabling more efficient and environmentally friendly drug manufacturing processes.
Codexis is also involved in the production of food ingredients, where its customized enzymes can enhance flavor, texture, and nutritional value. By working with food and beverage companies, Codexis helps improve product quality while addressing consumer demands for more sustainable and natural ingredients.
Furthermore, Codexis is engaged in the development of sustainable biofuels and biochemicals. By engineering enzymes to efficiently convert biomass into useful molecules, the company aims to contribute to a more sustainable and renewable energy future.
In summary, Codexis, Inc. leverages its protein engineering expertise to develop enhanced enzymes for a wide range of applications in pharmaceuticals, food production, and sustainable energy. Their focus on innovation and sustainability positions them as a leading provider of biocatalyst solutions to global partners and industries.